Related Experiment Video
Updated: Jun 24, 2026
Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
[Soft tissue infections]
Mónica Ibáñez Barceló1, Virginia Pomar Solchaga, Santos Castañeda
1Reumatología, Hospital Son Llàtzer, Palma de Mallorca, Baleares, España. mibanez@hsll.es
Abstract:
Soft tissue infections represent an emerging health problem with a growing incidence and mortality. The augmented incidence of skin and soft tissue infections is the result of a number of factors, such as the increase of immunocompromised patients, emergence of multidrug-resistant pathogens due to the irrational use of antibiotics and the ability of pathogens to adapt to the environment. Successful management requires a global performance that involves a surveillance program, appropriate empirical antibiotic therapy and prompt surgical exploration with extensive debridement of devitalized tissue. Staphylococcus aureus is the most common pathogen and, in the last few years, methicillin-resistant S. aureus (MRSA) has become commonplace. In Spain, the global incidence of MRSA is 29%; however, there are series in which rises to 46.4%. For this reason, MRSA will be highlighted in this revision.
Insights
Soft tissue infections are increasing due to resistant bacteria like MRSA. Effective management requires surveillance, proper antibiotics, and surgical debridement for better patient outcomes.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Context:
- Rising incidence and mortality of soft tissue infections globally.
- Contributing factors include immunocompromised patients and antibiotic resistance.
- Pathogen adaptability exacerbates infection spread.
Purpose:
- To review the current landscape of soft tissue infections.
- To highlight the growing threat of methicillin-resistant Staphylococcus aureus (MRSA).
- To emphasize optimal management strategies.
Summary:
- Soft tissue infections (STIs) pose a significant health challenge.
- Staphylococcus aureus, particularly MRSA, is a primary pathogen.
- Management involves surveillance, empirical antibiotic therapy, and surgical intervention.
Impact:
- Informed clinical decision-making for STIs.
- Enhanced understanding of MRSA prevalence and impact.
- Improved strategies for combating antibiotic-resistant infections.
Related Concept Videos
01:23Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
01:29Staphylococcal Skin Infections
01:26Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
01:22Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
01:25Endocarditis I: Introduction
01:26Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...